N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine

N-(5-{3,4-difluoro‑2‑[(2‑fluoro‑4‑iodophenyl)amino]phenyl}‑1,3,4‑oxadiazol‑2‑yl)ethane‑1,2‑diamine is a synthetic small molecule belonging to the class of substituted anilines and oxadiazoles. It has been catalogued in chemical and drug databases as an experimental compound but is not approved for clinical use. The compound features multiple halogen substitutions (fluorine and iodine), which are often associated with kinase inhibitor scaffolds. There is no direct evidence of its mechanism of action or therapeutic indication in humans; however—based on structural similarity to related compounds described in patents—it may have been investigated as a potential kinase inhibitor (such as MEK inhibition), but this specific molecule does not appear to have advanced into clinical trials or received regulatory approval[3][6].

Other names

N-(5-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)-1,3,4-oxadiazol-2-yl)ethane-1,2-diamineN-(5-{3,4-Difluoro-2-[ (2-Fluoro–4-Iodophenyl )Amino ]Phenyl }–1,3,4-Oxadiazol–2-Yl )Ethane–1,2-Diamine